ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]
ACAD/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.00 | 42.00 | 2.00 | 4.00 | 1.00 | - - | - - | 17.00 | 124.00 | 223.00 | 339.00 | 441.00 | 484.00 | 517.00 | 726.00 | |
|
EPS
|
-1.20 | 0.39 | -0.44 | -0.38 | -0.44 | -0.95 | -1.63 | -2.34 | -2.36 | -1.94 | -1.60 | -1.79 | -1.05 | -1.34 | -0.37 | |
| Diluted in mil. | -1.20 | 0.39 | -0.44 | -0.38 | -0.44 | -0.95 | -1.63 | -2.34 | -2.36 | -1.94 | -1.60 | -1.79 | -1.05 | -1.34 | -0.37 | |
|
Profit
|
6.00 | 42.00 | 2.00 | 4.00 | 1.00 | - - | - - | 12.00 | 111.00 | 205.00 | 319.00 | 421.00 | 465.00 | 507.00 | 680.00 | |
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 74.58 | 89.54 | 91.81 | 94.22 | 95.35 | 96.05 | 98.03 | 93.70 | |
| Pre Tax | -45.00 | 15.00 | -22.00 | -20.00 | -37.00 | -92.00 | -164.00 | -270.00 | -288.00 | -243.00 | -234.00 | -280.00 | -167.00 | -213.00 | -51.00 | |
| Profit Margin | -705.50 | 35.93 | -1,101.35 | -424.88 | -3,314.24 | -77,062.50 | -269,037.70 | -1,558.20 | -230.81 | -108.99 | -69.12 | -63.60 | -34.60 | -41.27 | -7.03 | |
| ETR | - - | - - | - - | 0.52 | - - | 0.22 | -0.20 | -0.50 | -0.39 | -0.51 | -0.37 | -0.22 | -0.21 | -1.19 | -20.08 | |
| Net | -45.00 | 15.00 | -22.00 | -20.00 | -37.00 | -92.00 | -164.00 | -271.00 | -289.00 | -245.00 | -235.00 | -281.00 | -167.00 | -215.00 | -61.00 | |
| Profit Margin | -705.50 | 35.93 | -1,101.35 | -424.88 | -3,314.24 | -77,062.50 | -269,578.69 | -1,565.94 | -231.71 | -109.56 | -69.38 | -63.74 | -34.67 | -41.76 | -8.44 | |
| EBITDA | -44.00 | 15.00 | -22.00 | -20.00 | -38.00 | -93.00 | -164.00 | -272.00 | -292.00 | -247.00 | -246.00 | -286.00 | -170.00 | -223.00 | -67.00 | |
| EBITDA Margin | -693.19 | 37.26 | -1,091.78 | -425.64 | -3,337.82 | -77,691.67 | -269,855.74 | -1,574.14 | -234.11 | -110.56 | -72.71 | -64.87 | -35.20 | -43.23 | -9.34 | |
| Operating Income | -45.00 | 15.00 | -22.00 | -20.00 | -38.00 | -93.00 | -164.00 | -272.00 | -292.00 | -247.00 | -246.00 | -286.00 | -170.00 | -223.00 | -73.00 | |
| Operating Margin | -710.55 | 35.82 | -1,105.56 | -425.64 | -3,344.72 | -77,691.67 | -269,855.74 | -1,574.14 | -234.11 | -110.56 | -72.71 | -64.87 | -35.20 | -43.23 | -10.10 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | 2.00 | 4.00 | 5.00 | 11.00 | 6.00 | - - | 6.00 | 17.00 | |
| Loss | -51.00 | -27.00 | -24.00 | -25.00 | -39.00 | -93.00 | -164.00 | -290.00 | -417.00 | -471.00 | -585.00 | -728.00 | -654.00 | -740.00 | -799.00 | |
| Cost of Revenue | - - | - - | - - | - - | - - | - - | - - | -4.00 | -13.00 | -18.00 | -19.00 | -20.00 | -19.00 | -10.00 | -45.00 | |
|
Operating Expenses
|
-51.00 | -27.00 | -24.00 | -25.00 | -39.00 | -93.00 | -164.00 | -285.00 | -404.00 | -452.00 | -566.00 | -707.00 | -635.00 | -730.00 | -754.00 | |
| R&D | -41.00 | -20.00 | -17.00 | -18.00 | -26.00 | -60.00 | -73.00 | -99.00 | -149.00 | -187.00 | -240.00 | -319.00 | -239.00 | -361.00 | -351.00 | |
| G&A | -10.00 | -6.00 | -7.00 | -6.00 | -12.00 | -32.00 | -90.00 | -186.00 | -255.00 | -265.00 | -325.00 | -388.00 | -396.00 | -363.00 | -393.00 | |
| SG&A | -10.00 | -6.00 | -7.00 | -6.00 | -12.00 | -32.00 | -90.00 | -186.00 | -255.00 | -265.00 | -325.00 | -388.00 | -396.00 | -369.00 | -402.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -38.00 | -51.00 | -41.00 | -5.00 | -9.00 | |
| Depreciation and Amortization | -1.00 | - - | - - | - - | - - | - - | - - | -1.00 | -2.00 | -3.00 | -2.00 | -2.00 | -3.00 | -2.00 | -5.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -6.00 | - - | |
| Other Expenses | - - | - - | - - | - - | - - | - - | - - | -2.00 | -4.00 | -1.00 | -12.00 | -5.00 | -2.00 | -10.00 | -22.00 | |
|
WA Shares Outstanding
|
37.00 | 38.00 | 52.00 | 54.00 | 85.00 | 97.00 | 100.00 | 115.00 | 122.00 | 126.00 | 147.00 | 157.00 | 160.00 | 161.00 | 163.00 | |
| Diluted | 37.00 | 38.00 | 52.00 | 55.00 | 85.00 | 97.00 | 100.00 | 115.00 | 122.00 | 126.00 | 147.00 | 157.00 | 160.00 | 161.00 | 163.00 |